Announcement of several contracts for the agreement of discounts pursuant to § 130a para. 8 SGB V for the active ingredient Interferon beta-1a (Rebif).
Announcement of several contracts for the agreement of discounts pursuant to § 130a para. 8 SGB V for the active compounds Dabigatran etexila and Rivaroxaban.
Announcement of several contracts for the agreement of discounts pursuant to § 130a para. 8 SGB V for the active ingredients Aripiprazole, Duloxetin and Paliperidon.